Nektar(NKTR) - 2023 Q4 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Conference Call March 4, 2024 5:00 PM ET Company Participants Vivian Wu - Director, Investor Relations and Corporate Affairs Howard Robin - President and Chief Executive Officer Jonathan Zalevsky - Chief Research & Development Officer Sandra Gardiner - Chief Financial Officer Mary Tagliaferri - Chief Medical Officer Conference Call Participants Cheng Li - Oppenheimer & Co. Inc. Kambiz Yazdi - Jefferies Group LLC Jessica Fye - JPMorgan Chase & Co. Julian Har ...